Overview
This Int J Immunopathol Pharmacol study from the Spedali Civili Brescia and University G. d’Annunzio Chieti SNAS-research groups is the canonical reference for the SNAS nosologic framework and the development of the BraMa-Ni diet as a diagnostic tool. 145 patients with suspected SNAS underwent oral nickel challenge for definitive diagnosis, and the BraMa-Ni structured low-nickel diet (~50 µg Ni/day, nutritionally balanced) was compared against the conventional forbidden-foods-list approach for sensitivity and specificity. The BraMa-Ni diet substantially outperformed the forbidden-food-list approach: 94.4 percent sensitivity and 93.3 percent specificity, versus 51.1 percent / 44.2 percent for the simpler list. The paper consolidates SNAS as a well-defined clinical entity with rigorous diagnostic criteria.
Key numbers
| Diagnostic approach | Sensitivity | Specificity |
|---|---|---|
| BraMa-Ni structured low-nickel diet (~50 µg Ni/day) | 94.4 percent | 93.3 percent |
| Conventional forbidden-foods list | 51.1 percent | 44.2 percent |
The BraMa-Ni diet is approximately 50 µg Ni/day (vs typical Western intake 150-350 µg/day), is nutritionally balanced, and serves both diagnostic and therapeutic functions.
Methods (brief)
145-patient cross-sectional study with suspected SNAS by history and prior benefit from Ni dietary restriction. All underwent standardized oral nickel challenge for definitive diagnosis. Each followed either BraMa-Ni structured diet or conventional forbidden-foods list. Sensitivity and specificity computed against the oral-challenge gold standard.
Implications
- Certification: Establishes SNAS as a well-defined clinical entity affecting approximately 20 percent of nickel-ACD patients and provides the validated diagnostic tool (BraMa-Ni diet). HMTc Ni-threshold rationale for vulnerable populations should reference SNAS prevalence and the BraMa-Ni framework when discussing dietary Ni intake at the population level.
- Microbiome / immunology: Both Th1 and Th2 pathways implicated; IL-5 most significantly elevated cytokine within 24 hours of oral challenge. Intestinal mucosa CD4+CD45RO+ infiltration documented.
- Courses: Foundational reference for SNAS diagnostic criteria.
Wiki pages updated on ingest
Update history
The five most recent substantive edits to this page, classified major (evidence or structure moved), correction (a published value or statement was wrong and has been fixed), or minor (narrative rewritten without changing the underlying evidence). Each description is derived from what the edit did to this page; the linked commit is the authoritative record, routine regeneration passes are excluded, and the full version history lives in git. When DOI minting comes online (see schema docs), each entry below will also link to a version-pinned DataCite DOI.
| Commit | Date | Change | Description |
|---|---|---|---|
| a8052bb | 2026-08-09 | major | 6 sections added; narrative text revised |